We strive to provide life-saving medicine
for people suffering from diseases,
including their families, around the world.
News
- Mar.2,2026 News release Notification of Change in Chief Executive Officer
3.74 KB
- Jan.26,2026 News release FIMECS Received A Notice for Patent Allowance
3.59 KB
- Nov.27,2025 News release Addition of New Targets in Joint Research with Astellas Pharma Inc.
3.54 KB
- Nov.17,2025 News release FIMECS to Present at the Australian Ubiquitin Summit 2025
- Sep.25,2025 News release FIMECS to Present at the 8th TPD & Induced Proximity Summit
- Sep.16,2025 News release FIMECS to Present at the 23rd Discovery on Target
- Jul.8,2025 News release Publication about the scAb-AID2 technology as a collaboration with National Institute of Genetics
3.38 KB
- Jun.20,2025 News release FIMECS organizes “3rd Targeted Protein Degradation Conference in Japan” This July
- Mar.31,2025 News release Notice of Executive Personnel Changes
3.34 KB
- Mar.31,2025 News release FIMECS Completed a Joint Research Project with Astellas Pharma Inc. to Receive a Lump-sum Payment
- Mar.3,2025 News release Notification of Change in Representative Director
3.26 KB
- Oct.25,2024 News release FIMECS Presents at the 7th TPD & Induced Proximity Summit
2.96 KB
- Sep.25,2024 News release Publication as a result of collaboration with Kyoto University
2.92 KB
- Jul.30,2024 News release RaQualia Group R&D Meeting Video Streaming
- Jul.22,2024 News release FIMECS Received A Notice for Patent Allowance
2.88 KB
- Jun.10,2024 News release RaQualia Group R&D Meeting on 21st July
2.80 KB
- Jun.10,2024 News release FIMECS Presents at the Frontiers of Drug Discovery 2024
2.72 KB
- May.18,2024 News release FIMECS Presents at the Protein Degradation in Focus
2.70 KB
- Mar.30,2024 News release FIMECS Presents at the 19th Annual Drug Discovery Chemistry
2.66 KB
- Mar.27,2024 News release FIMECS Appoints Two New Board Members
2.61 KB
Read More